DR. GLODERM TABRX WRINKLETOX- adenosine cream

Land: USA

Språk: engelska

Källa: NLM (National Library of Medicine)

Aktiva substanser:

ADENOSINE (UNII: K72T3FS567) (ADENOSINE - UNII:K72T3FS567)

Tillgänglig från:

DR.GLODERM

INN (International namn):

ADENOSINE

Sammansättning:

ADENOSINE 0.0428 g in 100 g

Administreringssätt:

TOPICAL

Receptbelagda typ:

OTC DRUG

Terapeutiska indikationer:

Skin Protectant - Anti-Wrinkle It's melting on the pam taken two capsules with spatula at the last stage of skin care, and apply on the entire face. Gently pat to help absorption into the skin. * Do not eat capsules.

Bemyndigande status:

unapproved drug other

Produktens egenskaper

DR. GLODERM TABRX WRINKLETOX- ADENOSINE CREAM
DR.GLODERM
_Disclaimer: This drug has not been found by FDA to be safe and
effective, and this labeling has not been_
_approved by FDA. For further information about unapproved drugs,
click here._
----------
DRUG FACTS
Adenosine
Water, Butylene Glycol, etc.
Skin Protectant - Anti-Wrinkle
keep out of reach of the children
It's melting on the pam taken two capsules with spatula at the last
stage of skin care, and apply on the
entire face.
Gently pat to help absorption into the skin.
* Do not eat capsules.
1. If the following symptoms occur after product use, stop using the
product immediately and consult a
dermatologist (continuous use can exacerbate the symptoms).
1) Occurrence of red spots, swelling, itchiness, and other skin
irritation
2) If the symptoms above occur after the application area is exposed
to direct sunlight
2. Do not use on open wounds, eczema, and other skin irritations
3. Precaution for Storage and Handling
1) Close the lid after use
2) Keep out of reach of infants and children
3) Do not to store in a place with high/low temperature and exposed to
direct sunlight
4. Use as avoiding eye areas.
for external use only
DR. GLODERM TABRX WRINKLETOX
adenosine cream
PRODUCT INFORMATION
PRODUCT T YPE
HUMAN OTC DRUG
ITE M CODE (SOURCE )
NDC:71342-0 0 13
ROUTE OF ADMINISTRATION
TOPICAL
ACTIVE INGREDIENT/ACTIVE MOIETY
INGREDIENT NAME
BASIS OF STRENGTH
STRE NG TH
ADENO SINE (UNII: K72T3FS56 7) (ADENOSINE - UNII:K72T3FS56 7)
ADENOSINE
0 .0 428 g in 10 0 g
INACTIVE INGREDIENTS
INGREDIENT NAME
STRE NG TH
GLYCERIN (UNII: PDC6 A3C0 OX)
WATER (UNII: 0 59 QF0 KO0 R)
BUTYLENE GLYCO L (UNII: 3XUS8 5K0 RA)
PACKAG ING
#
ITEM CODE
PACKAGE DESCRIPTION
MARKETING START DATE
MARKETING END DATE
1
NDC:71342-0 0 13-1
45 g in 1 JAR; Type 0 : No t a Co mbinatio n Pro duct
0 3/28 /20 17
MARKETING INFORMATION
MARKE TING CATE GORY
APPLICATION NUMBE R OR MONOGRAPH CITATION
MARKE TING START DATE
MARKE TING END DATE
unappro ved drug o ther
0 3/0 1/20 17
DR.GLODERM
LABELER -
DR.GLODERM (694